Navigation Links
FDA Approves Opioid Analgesic to Help Cancer Patients Manage Pain
Date:1/7/2011

SILVER SPRING, Md., Jan. 7, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Abstral (fentanyl) transmucosal tablets to manage breakthrough pain for adults with cancer.  Fentanyl immediate-release transmucosal medications are administered on the soft surfaces of the mouth (inside of the cheek, gums, tongue), or the nasal passages or throat where they dissolve and are absorbed.

(Logo:  http://photos.prnewswire.com/prnh/20090824/FDALOGO)

"This is an important step for patients with cancer pain to have options for the treatment of their breakthrough pain," said John Jenkins, M.D., director of FDA's Office of New Drugs in the Center for Drug Evaluation and Research.

Abstral is indicated for the management of breakthrough pain in patients with cancer, ages 18 years and older, who already use opioid pain medication around the clock and who need and are able to safely use high doses of an additional opioid medicine.  Breakthrough pain is pain that comes on suddenly for short periods of time and is not alleviated by a patient's normal pain management plan. These patients are considered opioid tolerant because of their current opioid medication use.  Only health care professionals skilled in the use of Schedule II opioids to treat pain should prescribe this drug product.  

Abstral is available only through a Risk Evaluation and Mitigation Strategy (REMS) program, which is intended to minimize the risk of misuse, abuse, addiction and overdose.  Under this program, pharmacies, distributors, and health care professionals who prescribe to outpatients are required to enroll in the program to prescribe, dispense and distribute this product.  FDA has standardized key components of the REMS program to facilitate the adoption of a single shared system. These components include the REMS document, th
'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. VIDEO from Endo Pharmaceuticals Available on thenewsmarket.com: FDA Approves New Treatment for Low Testosterone
2. FDA Approves New Dosage Strength for INTELENCE®
3. U.S. FDA Approves Second Bayer Oral Contraceptive That Also Raises Folate Levels
4. FDA Approves PREZISTA®/ritonavir Once-Daily Dosing for HIV-1 Treatment-Experienced Adults With No Darunavir Resistance-Associated Mutations
5. FDA Approves New Manufacturing Facility for Collagenase SANTYL® Ointment
6. Vermillion Reappoints Three Directors, Approves a New Stock Incentive Plan, and Ratifies PricewaterhouseCoopers LLP as Its Accounting Firm
7. FDA Approves Xgeva to Help Prevent Cancer-Related Bone Injury
8. FDA Approves New Treatment Option for Late-Stage Breast Cancer
9. FDA Approves Vyvanse® (lisdexamfetamine dimesylate) Capsules CII for the Treatment of ADHD in Adolescents
10. FDA Approves Cymbalta® for the Management of Chronic Musculoskeletal Pain
11. FDA Approves New Indication for Afinitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... , July 25, 2014  The Chemistry, Food ... Ministry of Health approved the introduction of Telaprevir ... the cure rate from Hepatitis C, and it ... 1 virus. Telaprevir is available in ... Photo - http://www2.prnewswire.com.br/imgs/pub/2014-07-25/original/2026.jpg   ...
(Date:7/25/2014)... July 25, 2014  Solanbridge Group Inc (OTC: SLNX) ... majority interest in Buzznbrewz.com and the Letter of Intent ... a fully executed Purchase Agreement. Charles ... are proud to have Mr. David Pecoraro ... experience in the private sector and developed a tremendous ...
(Date:7/25/2014)... July 25, 2014 Research and Markets ... Ophthalmic Diagnostic Devices Market 2014-2018" report to their ... About Ophthalmic Diagnostic Device An ... identify a defect or deficiency in the human visual ... disorders such as presbyopia, cataracts, glaucoma, retinal disorders, conjunctivitis, ...
Breaking Medicine Technology:The Hepatitis C virus is the main cause of liver transplant in the world 2The Hepatitis C virus is the main cause of liver transplant in the world 3Solanbridge Group Inc Announces Acquisition of Buzznbrewz.com 2Global Ophthalmic Diagnostic Devices Market 2014-2018: Key Vendors are Alcon, Carl Zeiss, Haag-Streit and Topcon 2
... Results of Largest Randomized, Placebo-controlled Trial,Ever Conducted ... of,Clinical Oncology, CHICAGO, June 04, 2007 /PRNewswire/ ... clinical trial ever,conducted in patients with cutaneous ... than twice as effective as placebo in ...
... in Patients With Follicular Lymphoma Reported,Today at ... /PRNewswire/ -- GlaxoSmithKline plc,announced today long-term efficacy ... a,single one-week course of frontline treatment with ... Tositumomab) in,76 patients with newly diagnosed advanced ...
Cached Medicine Technology:Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in,Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL) 2Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in,Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL) 3Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in,Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL) 4Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in,Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL) 5Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in,Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL) 68-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 28-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 38-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 48-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 58-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 68-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 7
(Date:7/28/2014)... 2014 Scientists in Japan have completed ... blood test for the asbestos cancer mesothelioma. Surviving Mesothelioma ... Click here to read it now. , ... Juntendo University Graduate School of Medicine say a new ... step above the old test. , “Particularly for ...
(Date:7/28/2014)... July 28, 2014 Maternal and Family ... Tucker Award, which will be presented at the agency’s ... October 29th at the Westmoreland Club in Wilkes-Barre. , ... Commissioner and long-time employee of MFHS. She dedicated ... political activist, health advocate, and champion for women, children ...
(Date:7/28/2014)... that following a healthy lifestyle may lower childhood cancer ... online in CANCER , a peer-reviewed journal of ... with cancer and adults who had cancer when they ... may influence their long-term health. , Adults who ... increased risk for the metabolic syndrome, a group of ...
(Date:7/28/2014)... As health insurers design their strategies ... exchanges. “Private Exchange Strategies for Insurers: What’s Working? ... Information Services, will provide answers to the big-dollar questions ... future. , Barbara Gniewek, Jonathan Har-Even and Martin Hill ... the private exchange sector — will provide expert presentations ...
(Date:7/28/2014)... GA (PRWEB) July 28, 2014 Mitul ... the nation gathered at the MGE Management Experts Benefit ... and community leaders joined the Dentists to raise funds ... the Boys and Girls Clubs and Youth Programs across ... of young people with books and audio books to ...
Breaking Medicine News(10 mins):Health News:Test Results Look Promising for New Mesothelioma Blood Test, According to Surviving Mesothelioma 2Health News:MFHS Seeking Nominations for Rose Allan Tucker Award 2Health News:Lifestyle choices may affect the long-term heart health of childhood cancer survivors 2Health News:Three PwC Consultants to Offer Insurers Successful Strategies for Private Exchanges 2Health News:Mitul R. Patel, DDS Successfully Attacks a Major Source of Economic Destruction in the Battle Against Illiteracy and Poverty 2Health News:Mitul R. Patel, DDS Successfully Attacks a Major Source of Economic Destruction in the Battle Against Illiteracy and Poverty 3
... Results from two,studies comparing colorectal cancer screening ... called virtual colonoscopy),have sparked interest in colorectal cancer ... consumers. The studies, one a large multi-center,trial sponsored ... other from the,University of Wisconsin published in the ...
... Health COO First Annual Honoree, SOMERSET, N.J., Oct. ... (Nasdaq: VTIV ) and President and CEO,of inVentiv ... Big,Brothers Big Sisters(R) (BBBS) of Hunterdon & Somerset Counties ... Moments, Big Magic -- A,Match That Lights an Eternal ...
... Liver, NEW YORK, Oct. 5 Urging every ... (ALF) today observed Liver,Awareness Month by releasing 12 tips ... Liver disease, a serious and largely unrecognized problem in ... among adults between the ages of,25 and 64, taking ...
... month a collaboration of European and Asian researchers launched ... harnessing the combined power of more than 40,000 computers ... drug discovery. , Called Enabling Grids for E-sciencE, the ... supercomputer that is being used during this challenge to ...
... Tenn., Oct. 5 Emdeon Business Services,announced ... Delta Dental payers for,insurance eligibility and benefits ... vendor partners and through the Emdeon suite ... Provider Services,(DPS), Emdeon,s interactive web portal. Emdeon ...
... Mich., Oct. 5 Volkswagen of America,Inc., in ... Volkswagen,dealers, proudly announces its 12th consecutive year of ... delighted to continue our sponsorship for our 12th ... "The LaSalle Bank,Chicago Marathon is a great opportunity ...
Cached Medicine News:Health News:Frequently Asked Questions When Considering a Colorectal Cancer Screening Test, From the American College of Gastroenterology 2Health News:Frequently Asked Questions When Considering a Colorectal Cancer Screening Test, From the American College of Gastroenterology 3Health News:Terrell Herring Honored by Big Brothers Big Sisters 2Health News:October is Liver Awareness Month: The American Liver Foundation Urges All Americans to Pay Attention to Their Liver Every Day of the Year 2Health News:October is Liver Awareness Month: The American Liver Foundation Urges All Americans to Pay Attention to Their Liver Every Day of the Year 3Health News:Grid computing offers new hope in race against bird flu 2Health News:Emdeon Business Services Extends Market Leadership With New Dental Eligibility Payers 2Health News:Volkswagen Continues Sponsorship of the Lasalle Bank Chicago Marathon 2
... PROXIMATE Access 55 Articulating Linear Staplers are ... or a thick-tissue green instrument (non-reloadable). Each ... 55mm staple line., ,Benefits include: , ... in narrow male pelvis. , Articulating head ...
... Staplers deliver two staggered rows of titanium staples ... be reloaded up to three times for a ... wire staples for thick tissue. The TLV model ... ,Benefits include: , Parallel jaw closure ensures that ...
... Loading Units With Titanium Staples ... TA™ (Single Use Reloadable Stapler ... Auto Suture™ PREMIUM MULTIFIRE TA™ ... gynecological, pediatric and thoracic surgical ...
Single Use Reloadable Stapler with Titanium Staples., ,The Auto Suture™ PREMIUM MULTIFIRE TA™ stapler has applications in abdominal, gynecological, pediatric and thoracic surgical proced...
Medicine Products: